the present studies were undertaken to examine the effectiveness of anti-sclc rat monoclonal antibodies lca1 and lc66 plus human complement combined with a derivative of cyclophosphamide ( asta-z 7557 ) for the elimination of cancerous clonogenic cells from the graft .
C0149925
the
C0334227
cancerous